EXPLORE OUR EDUCATION & RESOURCES

Complications Diabetic Vitrectomy & TRD Basics Surgical Technique Video Library Vitrectomy Basics Scleral Buckle Basics Reading List Clinical Trial Guide Case of the Month Image of the Month
Home About

Resources

VBS Videos VBS Publications Journal Club
VBS Sponsors Contact
  • Home
  • EXPLORE OUR EDUCATION & RESOURCES

  • Complications Diabetic Vitrectomy & TRD Basics Surgical Technique Video Library Vitrectomy Basics Scleral Buckle Basics Reading List Clinical Trial Guide Case of the Month Image of the Month
  • About
  • Resources

  • VBS Videos VBS Publications Journal Club
  • VBS
  • Sponsors
  • Contact

MENU

Hero Image

Featured Instrumentation

Vit-Buckle Academy and the Vit-Buckle Society proudly recognize and thank our industry sponsors for their generous support.

Genentech logo Vabysmo logo

Faricimab-svoa (Vabysmo®) from Genentech is the only FDA-approved dual-pathway therapy for exudative macular degeneration, diabetic macular edema, and retinal vein occlusion. Targeting VEGF and Ang-2, pivotal trial data has shown rapid and sustained efficacy across diseases. The novel combination of targets allows for delivery as a first-line agent with the ability to extend patients out to four months between injections. Genentech is committed to delivering safe and effective tools for vitreoretinal specialists and their patients, and continuing to partner with leaders and students in the field alike to improve patient outcomes.

Learn More
Home About Sponsors VBS Website Become a Member Become a Sponsor VBS Videos VBS Publications Journal Club Privacy Policy Terms of Use
VBS Logo
FB Logo TW Logo LI Logo

SIGN UP FOR UPDATES

Education

COMPLICATIONS DIABETIC VITRECTOMY & TRD BASICS Surgical Technique Library VITRECTOMY BASICS SCLERAL BUCKLE BASICS Clinical Trial Guides Case of the Month Image of the Month Reading List